QuantRx Debuts Flagship Diagnostic Reader Device (Q-Reader™) At MEDICA 2009, The World's Leading Medical Trade Fair

Main Category: Medical Devices / Diagnostics
Article Date: 09 Nov 2009 - 4:00 PST

email to a friend   printer friendly   view / write opinions   rate article

QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced that the Company will demonstrate its latest technology at MEDICA 2009, the world's leading medical trade fair, to be held November 18-21, 2009, in Düsseldorf, Germany. The trade show will be host to a milestone event for QuantRx as the point-of-care (POC) medical device pioneer will introduce for the first time its flagship diagnostic reader device, Q-Reader™.

QuantRx has been developing a platform of POC devices to facilitate diagnosis of critical metabolic markers, such as those associated with thyroid disease, malignant cancers, therapeutic drugs and other medically relevant conditions, as part of its QN Diagnostics initiative This unique platform technology, which combines the incredible sensitivity of our RapidSense® technology with the ultra-portable Q-Reader, enables the use of any biological sample, such as blood, urine, vaginal fluids, or saliva, to deliver laboratory results to the primary care provider in minutes.

"MEDICA 2009 sets the stage for the debut of an extraordinary new point-of-care system that is capable of significantly improving medical diagnostic procedures while potentially lowering healthcare costs," said Walter Witoshkin, QuantRx Chairman and Chief Executive Officer. "Our products are intended to provide front-line information needed by healthcare professionals to aid timely diagnosis for earlier intervention and immediate treatment, which can limit the spread of the disease within the patient, while providing greater patient convenience."

Dr. William H. Fleming, QuantRx Chief Scientific Officer, noted: "While we have had success with our positive/negative point-of-care tests, the combination of our existing RapidSense technology with our new reader presents for the first time the opportunity to quickly and cost effectively provide results to the healthcare practitioner that were previously limited to clinical laboratory testing. Based on the high level of interest that international distributors have expressed about our Q-Reader platform, we are preparing for an incredibly successful MEDICA 2009."

As the world's largest medical trade fair accompanied by a congress, this year's MEDICA will offer a comprehensive overview of a wide variety of innovations in the world of medicine, including the latest developments in healthcare diagnostic technology. Nearly 136,000 healthcare and related constituents participated in MEDICA 2008, with nearly half of the attendants visiting from outside of Europe. MEDICA 2009 takes place from November 18-21, 2009, from 9:00 a.m. - 5:30 p.m. each day, at the congress centers CCD South, CCD Pavilion and CCD East in Düsseldorf. For information on MEDICA 2009 and to download the program for the MEDICA Congress 2009, visit: http://www.medica.de.

Separately, the Company also announced today that it will hold its 2009 Annual General Meeting of Shareholders (AGM) on Thursday, December 3, 2009, at 10:00 a.m. local time, at Multnomah Athletic Club located at 1849 SW Salmon Street, Portland, Oregon 97205. Shareholders of record at the close of business on October 30, 2009 will receive copies of the meeting notice and proxy materials.

Source
QuantRx Biomedical